135 related articles for article (PubMed ID: 9632142)
1. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.
Zisch AH; Kalo MS; Chong LD; Pasquale EB
Oncogene; 1998 May; 16(20):2657-70. PubMed ID: 9632142
[TBL] [Abstract][Full Text] [Related]
2. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
[TBL] [Abstract][Full Text] [Related]
3. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
Yu HH; Zisch AH; Dodelet VC; Pasquale EB
Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
[TBL] [Abstract][Full Text] [Related]
4. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
[TBL] [Abstract][Full Text] [Related]
5. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.
Choi S; Park S
Oncogene; 1999 Sep; 18(39):5413-22. PubMed ID: 10498895
[TBL] [Abstract][Full Text] [Related]
7. Multiple in vivo tyrosine phosphorylation sites in EphB receptors.
Kalo MS; Pasquale EB
Biochemistry; 1999 Oct; 38(43):14396-408. PubMed ID: 10572014
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites.
Smalla M; Schmieder P; Kelly M; Ter Laak A; Krause G; Ball L; Wahl M; Bork P; Oschkinat H
Protein Sci; 1999 Oct; 8(10):1954-61. PubMed ID: 10548040
[TBL] [Abstract][Full Text] [Related]
11. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
12. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
13. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
14. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
15. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
16. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.
Labrador JP; Brambilla R; Klein R
EMBO J; 1997 Jul; 16(13):3889-97. PubMed ID: 9233799
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors.
Binns KL; Taylor PP; Sicheri F; Pawson T; Holland SJ
Mol Cell Biol; 2000 Jul; 20(13):4791-805. PubMed ID: 10848605
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis and yeast two-hybrid studies of the insulin and insulin-like growth factor-1 receptors: the Src homology-2 domain-containing protein hGrb10 binds to the autophosphorylated tyrosine residues in the kinase domain of the insulin receptor.
Dong LQ; Farris S; Christal J; Liu F
Mol Endocrinol; 1997 Nov; 11(12):1757-65. PubMed ID: 9369444
[TBL] [Abstract][Full Text] [Related]
20. Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).
Davis TL; Walker JR; Loppnau P; Butler-Cole C; Allali-Hassani A; Dhe-Paganon S
Structure; 2008 Jun; 16(6):873-84. PubMed ID: 18547520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
